Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.

We highlight that overlapping effects of genetic background and primary cancer treatment contribute to the development of second cancers after treatment of pediatric solid tumors. A comprehensive analysis of germline and tumor samples may be useful to predict the risk of secondary cancers.